Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rouz Darou Pharmaceutical Company is a prominent Iranian pharmaceutical manufacturer established in 1983 and headquartered in Tehran. The company specializes in the development and production of a diverse range of generic medicines, including oral solids, liquids, and nutritional supplements. Its extensive product portfolio addresses critical therapeutic areas such as cardiovascular health, gastroenterology, endocrinology, and infectious diseases. Rouz Darou operates state-of-the-art manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards to ensure product quality and safety. As a publicly traded entity on the Tehran Stock Exchange, the company plays a vital role in the domestic healthcare market by providing affordable and accessible medications. Rouz Darou continues to expand its reach through exports to regional markets in the Middle East and Central Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RouzDarou.